The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Mechanisms linking obesity with cardiovascular disease
Abstract
Obesity increases the risk of cardiovascular disease and premature death. Adipose tissue releases a large number of bioactive mediators that influence not only body weight homeostasis but also insulin resistance - the core feature of type 2 diabetes - as well as alterations in lipids, blood pressure, coagulation, fibrinolysis and inflammation, leading to endothelial dysfunction and atherosclerosis. We are now beginning to understand the underlying mechanisms as well as the ways in which smoking and dyslipidaemia increase, and physical activity attenuates, the adverse effects of obesity on cardiovascular health.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity is strongly associated with the development of major risk factors for atherosclerotic disease such as hypertension, hyperlipidemia, and diabetes (79, 89, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
In the citing paper
“In addition, endothelial dysfunction is widely present in obesity and the metabolic syndrome (84, 325, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
In the citing paper
“In other populations, such as those in the STRONG heart study (native Americans of the western United States) and the Framingham heart study, diabetes or the metabolic syndrome do appear to be significant risk factors for LV hypertrophy (272, 306, 358).”
From Cardiac remodeling in obesity (2008) · cites this paper as [358]
Citations
Cites
1 retracted
Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of Insulin
Fukuhara, A., Matsuda, M., Nishizawa, M., Segawa, K., Tanaka, M., Kishimoto, K., Matsuki, Y., Murakami, M., Ichisaka, T., Murakami, H., et al. (2005) · Science · doi:10.1126/science.1097243 · Cited by 1,906
RetractedYusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and Atherosclerosis
Libby, P., Ridker, P. M., & Maseri, A. (2002) · Circulation · doi:10.1161/hc0902.104353 · Cited by 7,724
Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382302 · Cited by 4,032
Poirier, P., Giles, T. D., Bray, G. A., Hong, Y., Stern, J. S., Pi-Sunyer, F. X., & Eckel, R. H. (2006) · Circulation · doi:10.1161/circulationaha.106.171016 · Cited by 3,165
Obesity and the risk of heart failure
Kenchaiah, S., Evans, J. C., Levy, D., Wilson, P. W. F., Benjamin, E. J., Larson, M. G., Kannel, W. B., & Vasan, R. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020245 · Cited by 3,093
Yusuf, S., Hawken, S., Ôunpuu, S., Bautista, L., Franzosi, M. G., Commerford, P., Lang, C. C., Rumboldt, Z., Onen, C. L., Lisheng, L., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67663-5 · Cited by 2,903
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Overweight, Obesity, and Mortality in a Large Prospective Cohort of Persons 50 to 71 Years Old
Adams, K. F., Schatzkin, A. G., Harris, T. B., Kipnis, V., Mouw, T., Ballard-Barbash, R. R., Hollenbeck, A. R., & Leitzmann, M. F. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055643 · Cited by 2,147
Flagged first, then by citations
Cited by
Sorted by citations
Items 701–800 of 1,009
Dharuri, H. K., Hoen, P. A. C. ’., van Klinken, J. B., Henneman, P., Laros, J. F. J., Lips, M. A., el Bouazzaoui, F., van Ommen, G. B., Janssen, I. M. C., van Ramshorst, B., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3347-0 · Cited by 52
“Obesity results in decreased life expectancy due to associated metabolic and cardiovascular disorders, as well as several types of cancer [2, 3].”
BackgroundZhao, M., Cooney, M. T., Klipstein‐Grobusch, K., Vaartjes, I. C. H., Bacquer, D. D., SUTTER, J. D., Reiner, Ž., Prescott, E., Faggiano, P. M., Vanuzzo, D., et al. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316647827 · Cited by 50
“Among these modifiable risk factors, the high rate of obesity is of particular concern as it is strongly associated with raised blood pressure, cholesterol and glucose.(13) Current uniform body mass index (BMI) cut-off values for obesity may not be appropriate, especially for ethnic minorities, resulting in either ove…”
BackgroundDarios, E. S., Winner, B. M., Charvat, T. T., Krasinksi, A., Punna, S., & Watts, S. W. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00998.2015 · Cited by 49
Perry, B. I., Osimo, E. F., Upthegrove, R., Mallikarjun, P. K., Yorke, J., Štochl, J., Pérez, J., Zammit, S., Howes, O. D., Jones, P. B., et al. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00114-0 · Cited by 50
Impact of body-composition methodology on the composition of weight loss and weight gain
Pourhassan, M., Schautz, B., Braun, W., Gluer, C.-C., Bosy-Westphal, A., & Müller, M. J. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.35 · Cited by 43
Depressive symptoms, anxiety and well-being among metabolic health obese subtypes
Phillips, C. M., & Perry, I. J. (2015) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.07.168 · Cited by 48
“…as it is associated with increased risk of developing co-morbidities including metabolic syndrome (MetS), type 2 diabetes mellitus (T2DM) and cardiovascular disease (CVD) (Mokdad et al., 2003; Van Gaal et al., 2006), leading to increased risk of premature death and higher all-cause mortality.”
Santos, H. O., & Lavie, C. J. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.01.033 · Cited by 48
Milek, M., Moulla, Y., Kern, M., Stroh, C., Dietrich, A., Schön, M. R., Gärtner, D., Lohmann, T., Dreßler, M., Kovacs, P. L., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042222 · Cited by 56
“Altered secretion of adipokines and changes in AT metabolites release may link obesity to AT dysfunction and obesity-related cardiometabolic diseases [4,6,7,11,12].”
BackgroundAdipocytokines, C-Reactive Protein, and Cardiovascular Disease: A Population-Based Prospective Study
Seven, E., Husemoen, L. L. N., Sehested, T. S. G., Ibsen, H., Wachtell, K., Linneberg, A. R., & Jeppesen, J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128987 · Cited by 50
Vissers, D. K., Neels, H., Vermandel, A., Wachter, S. D., Tjalma, W. A. A., Wyndaele, J.-J., & Taeymans, J. (2014) · Obesity Reviews · doi:10.1111/obr.12170 · Cited by 49
“It has become clear that adipocytokines do not only play a role in energy homeostasis but also in insulin resistance, diabetes and inflammation, linking obesity to premature atherosclerosis (44,45).”
BackgroundDahlhoff, C., Desmarchelier, C., Sailer, M., Fürst, R. W., Haag, A., Ulbrich, S. E., Hummel, B., Obeid, R., Geisel, J., Bader, B., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057387 · Cited by 48
“accumulation [3,4].”
Hermsdorff, H. H. M., Puchau, B., Zulet, M. Á., & Martínez, J. A. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2009.0125 · Cited by 48
Treatment of Chronic Obstructive Pulmonary Disease and Its Comorbidities
Luppi, F., Franco, F., Beghé, B., & Fabbri, L. M. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200809-101th · Cited by 48
Guauque-Olarte, S., Gaudreault, N., Piché, M., Fournier, D., Mauriège, P., Mathieu, P., & Bossé, Y. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019908 · Cited by 48
Hemostasis at Extremes of Body Weight
Hunt, B. J. (2018) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0038-1661385 · Cited by 48
Acrylamide induces adipocyte differentiation and obesity in mice
Lee, H.-W., & Pyo, S. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.10.021 · Cited by 48
Saad, F., Doros, G. D., Haider, K. S., & Haider, A. (2020) · International Journal of Obesity · doi:10.1038/s41366-019-0517-7 · Cited by 49
Wang, J., Wu, M., Wu, S., & Tian, Y. (2022) · ESC Heart Failure · doi:10.1002/ehf2.13820 · Cited by 49
“It is well known that obesity is a major modifiable risk factor for cardiovascular diseases (CVD) and strongly associated with the occurrence of HF.(9,10) Compared with the general obesity represented by body mass index (BMI), abdominal obesity has been proposed to be a much stronger risk factor for CVD.”
BackgroundZhao, Y., Qie, R., Han, M., Huang, S., Wu, X., Zhang, Y., Feng, Y., Yang, X., Li, Y., Wu, Y., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.03.003 · Cited by 50
Liu, B., Tang, Y., Song, Z., & Ge, J. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12140 · Cited by 47
“Obesity and overweight are known to adversely affect human health and the risks and prognosis for a number of serious medical conditions, such as type 2 diabetes and cardiovascular disease, liver diseases, cardiovascular diseases and even cancer (2,3).”
BackgroundMicrowave-assisted synthesis of new benzimidazole derivatives with lipase inhibition activity
Menteşe, E., Bektaş, H., Ülker, S., Bekircan, O., & Kahveci, B. (2013) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2012.753880 · Cited by 47
Nakamura, F., Ishida, Y., Aihara, K., Sawada, D., Ashida, N., Sugawara, T., Aoki, Y., Takehara, I., Takano, K., & Fujiwara, S. (2016) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v27.30312 · Cited by 47
Relief of oxidative stress and cardiomyocyte apoptosis by using curcumin nanoparticles
Li, J., Zhou, Y., Zhang, W., Bao, C., & Xie, Z. (2017) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2017.02.023 · Cited by 47
Li, H., Hu, B., Wei, L., Zhou, L., Zhang, L., Lin, Y., Qin, B., Dai, Y., & Lu, Z. (2017) · European Journal of Neurology · doi:10.1111/ene.13556 · Cited by 47
“Insulin resistance has been shown to contribute to impairments in non-esterified fatty acid metabolism [27].”
BackgroundBuchan, L. J., Aubin, C. R. S., Fisher, A., Hellings, A., Castro, M. J., Al‐Nakkash, L., Broderick, T. L., & Plochocki, J. H. (2018) · BMC Research Notes · doi:10.1186/s13104-018-3862-z · Cited by 47
Assessment of anthropometric indices other than BMI to evaluate arterial stiffness
Haraguchi, N., Koyama, T., Kuriyama, N., Ozaki, E., Matsui, D., Watanabe, I., Uehara, R., & Watanabe, Y. (2019) · Hypertension Research · doi:10.1038/s41440-019-0264-0 · Cited by 48
Short sleep duration is related to emerging cardiovascular risk factors in obese children
Navarro‐Solera, M., Carrasco‐Luna, J., Pin‐Arboledas, G., González‐Carrascosa, R., Soriano, J. M., & Codoñer‐Franch, P. (2015) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000000868 · Cited by 46
“Adipokines such as leptin and adiponectin are bioactive molecules that link obesity to cardiovascular risk (16), and ghrelin is a hormone secreted by the stomach, which has a major effect on appetite and hence on obesity.”
BackgroundWu, J., Yang, Y., Zhang, J., Yu, H., 李立强, & Sun, Y. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1194779 · Cited by 75
“org In addition to total body fat, abdominal adiposity correlates closely with all-cause mortality (94).”
BackgroundCharacteristics of Urban Sidewalks/Streets and Objectively Measured Physical Activity
Suminski, R. R., Jr., Heinrich, K. M., Poston, W. S. C., Hyder, M., & Pyle, S. A. (2007) · Journal of Urban Health · doi:10.1007/s11524-007-9251-x · Cited by 46
Farag, N. H., Moore, W. E., Lovallo, W. R., Mills, P. J., Khandrika, S., & Eichner, J. E. (2008) · Journal of Women s Health · doi:10.1089/jwh.2008.0866 · Cited by 46
Wasmund, S. L., Owan, T., Yanowitz, F. G., Adams, T. D., Hunt, S. C., Hamdan, M. H., & Litwin, S. E. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.10.023 · Cited by 48
Kristensen, M., & Bügel, S. (2011) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2011.102 · Cited by 46
Influence of gender, BMI and Hispanic ethnicity on physical activity in children
Byrd-Williams, C. E., Kelly, L. A., Davis, J. N., Spruijt‐Metz, D., & Goran, M. I. (2007) · International Journal of Pediatric Obesity · doi:10.1080/17477160701369167 · Cited by 46
Romain, C., Gaillet, S., Carillon, J., Vidé, J., Ramos, J., Izard, J., Cristol, J., & Rouanet, J. (2012) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf303549t · Cited by 48
Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients
Vachatova, S., Andrýs, C., Krejsek, J., Salavec, M., Ettler, K., Řeháček, V., Čermáková, E., Málková, A., Fiala, Z., & Borská, L. (2016) · Journal of Immunology Research · doi:10.1155/2016/5380792 · Cited by 46
Öztürk, K., Doğan, T., Çelikkanat, S., Özen, A., Demirci, H., Kurt, Ö., Türker, T., Yilmaz, Y. N., & Uygun, A. (2018) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001059 · Cited by 46
Mertens, J., Block, C. E. M. D., Spinhoven, M. J., Driessen, A. L. C., Francque, S., & Kwanten, W. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.768576 · Cited by 48
Circadian Clocks, Redox Homeostasis, and Exercise: Time to Connect the Dots?
McClean, C. M., & Davison, G. W. (2022) · Antioxidants · doi:10.3390/antiox11020256 · Cited by 46
Harrington, J., Peña, A. S., Gent, R. J., Hirte, C., & Couper, J. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04309.x · Cited by 46
Rossi, R., Iaccarino, D., Nuzzo, A. M., Chiurlia, E., Bacco, L., Venturelli, A., & Modena, M. G. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.09.001 · Cited by 46
Kahveci, B., Menteşe, E., Özil, M., Ülker, S., & Ertürk, M. (2013) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-012-0916-0 · Cited by 47
Joseph, G., Tarnow, L., Astrup, A. S., Hansen, T. K., Parving, H., Flyvbjerg, A., & Frystyk, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1910 · Cited by 48
Qin, X., Chen, C., Wang, J., Cai, A., Feng, X., Jiang, X., & Feng, Y. (2023) · BMC Cardiovascular Disorders · doi:10.1186/s12872-023-03543-x · Cited by 52
Matrix metalloproteinase-9 genetic variations affect MMP-9 levels in obese children
Belo, V. D. A., Souza-Costa, D. C., Luizon, M. R., Lanna, C. M. M., Carneiro, P. C., Izidoro‐Toledo, T. C., Ferraz, K. C., & Tanus-Santos, J. E. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.169 · Cited by 45
Bressan, J., Hermsdorff, H. H. M., Zulet, M. Á., & Martínez, J. A. (2009) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302009000500010 · Cited by 45
Fukuda, M., Nakamura, T., Kataoka, K., Nako, H., Tokutomi, Y., Dong, Y., Yasuda, O., Ogawa, H., & Kim‐Mitsuyama, S. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.170373 · Cited by 45
Growth hormone therapy improves exercise capacity in adult patients with Prader-Willi syndrome
Gondoni, L. A., Vismara, L., Marzullo, P., Vettor, R., Liuzzi, A., & Grugni, G. (2008) · Journal of Endocrinological Investigation · doi:10.1007/bf03349255 · Cited by 46
Using gene expression to predict the secretome of differentiating human preadipocytes
Mutch, D. M., Rouault, C., Kéophiphath, M., Lacasa, D., & Clément, K. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.3 · Cited by 45
Urbonavičienė, G., Frystyk, J., Flyvbjerg, A., Urbonavičius, S., Henneberg, E. W., & Lindholt, J. S. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.03.030 · Cited by 45
“obesity, insulin resistance and type-2 diabetes, and this proinflammatory condition has been causally linked to the development of CVD [3,4].”
BackgroundRusso, I. (2012) · Scientifica · doi:10.6064/2012/525374 · Cited by 47
“For the high risk of cardiovascular morbidity and mortality, metabolic syndrome represents a relevant problem in the clinical practice which re�uires an ade�uate de�nition of the complex cluster of pathogenetic factors [7, 10, 219], in order to propose multiple intervention strategies and to provide standardized guide…”
BackgroundTahara, N., Yamagishi, S., Kodama, N., Tahara, A., Honda, A., Nitta, Y., Igata, S., Matsui, T., Takeuchi, M., Kaida, H., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3896 · Cited by 45
“Obesity is a well-recognized risk factor for metabolic syndrome and atherosclerotic cardiovascular disease (1).”
Mediators of the Effect of Body Mass Index on Coronary Heart Disease
Lu, Y., Hajifathalian, K., Rimm, E. B., Ezzati, M., & Danaei, G. (2015) · Epidemiology · doi:10.1097/ede.0000000000000234 · Cited by 45
Expression of miR-199a-3p in human adipocytes is regulated by free fatty acids and adipokines
Gu, N., You, L., Shi, C., Yang, L., Pang, L., Cui, X., Ji, C., Zheng, W. L., & Guo, X. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5379 · Cited by 45
Interactive effects of obesity and physical fitness on risk of ischemic heart disease
Crump, C., Sundquist, J., Winkleby, M. A., & Sundquist, K. (2016) · International Journal of Obesity · doi:10.1038/ijo.2016.209 · Cited by 46
“, C-reactive protein and fibrinogen) that are associated with IHD risk,(50) possibly mediated by oxidative stress and endothelial dysfunction leading to atherosclerosis.(46)”
BackgroundQi, D., Wang, D., Zhang, C., Tang, X., He, J., Zhao, Y., Deng, W., & Deng, X. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3176 · Cited by 45
“Obesity, particularly visceral obesity, has been reported to impair systemic vasculature and is involved in the initiation and progression of cardiovascular diseases (9,10).”
BackgroundLiddle, D. M., Hutchinson, A. L., Wellings, H. R., Power, K. A., Robinson, L. E., & Monk, J. M. (2017) · Nutrients · doi:10.3390/nu9121289 · Cited by 47
“Dietary n-3 Polyunsaturated Fatty Acids as a Strategy to Modulate Adipose Tissue Dysfunction in Obesity Strategies to modulate adipokine synthesis and secretion from AT are warranted to attenuate the chronic low-grade inflammation that causally links obesity to pathologies such as systemic IR, CVD and T2D [14,26,27,60…”
BackgroundInfluentialKord‐Varkaneh, H., Ghaedi, E., Nazary-Vannani, A., Mohammadi, H., & Shab‐Bidar, S. (2018) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1451820 · Cited by 49
Development of optical nanoprobes for molecular imaging of reactive oxygen and nitrogen species
Xu, Z. J., & Pu, K. (2018) · Nano Research · doi:10.1007/s12274-018-2135-4 · Cited by 45
Maghsoudi, A. S., Hassani, S., Momtaz, S., Shadboorestan, A., Ganjali, M. R., Ghahremani, M. H., Hosseini, R., Norouzi, P., & Abdollahi, M. R. (2018) · Toxicology · doi:10.1016/j.tox.2018.10.014 · Cited by 45
Saeidi, A., Haghighi, M. M., Kolahdouzi, S., Daraei, A., Abderrahman, A. B., Essop, M. F., Laher, I., Hackney, A. C., & Zouhal, H. (2020) · Obesity Reviews · doi:10.1111/obr.13090 · Cited by 50
Genetics of Obesity in East Asians
Sun, C., Kovacs, P. L., & Guiu‐Jurado, E. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.575049 · Cited by 47
“…has become a public health problem throughout the world, whether in developing or developed countries (Ng et al., 2014), and is well recognized as a risk factor for a wide variety of health problems such as diabetes, dyslipidemia, hypertension, and cardiovascular diseases (Van Gaal et al., 2006).”
BackgroundBi, H., Zhang, Y., Qin, P., Wang, C., Peng, X., Chen, H., Zhao, D., Xu, S., Wang, L., Zhao, P., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.022633 · Cited by 47
A therapeutic role for vitamin D on obesity-associated inflammation and weight-loss intervention
Slusher, A. L., McAllister, M. J., & Huang, C. (2015) · Inflammation Research · doi:10.1007/s00011-015-0847-4 · Cited by 47
“the pathology of metabolic imbalances [11, 12].”
BackgroundThe Relationship between Maternal Plasma Leptin and Adiponectin Concentrations and Newborn Adiposity
Castro, N. P., Euclydes, V. V., Simões, F. A., Vaz-de-Lima, L. R., de Brito, C. A., Luzia, L., Devakumar, D., & Rondó, P. (2017) · Nutrients · doi:10.3390/nu9030182 · Cited by 28
“Adiponectin, a cytokine also produced by adipose tissue, is known for its insulin sensitization action and anti-atherogenic properties [8,10].”
BackgroundSong, Y., Tan, Y., Deng, M., Shan, W., Zheng, W., Zhang, B., Cui, J., Feng, L., Shi, L., Zhang, M., et al. (2023) · MedComm · doi:10.1002/mco2.413 · Cited by 48
Association analyses of GIP and GIPR polymorphisms with traits of the metabolic syndrome
Nitz, I., Fisher, E., Weikert, C., Burwinkel, B., Li, Y., Möhlig, M., Boeing, H., Schreiber, S., Schrezenmeir, J., & Döring, F. (2007) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200700048 · Cited by 44
Blockade of lipid accumulation by silibinin in adipocytes and zebrafish
Suh, H. J., Cho, S. Y., Kim, E. Y., & Choi, H. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.12.027 · Cited by 43
Kuniyasu, A., Tokunaga, M., Yamamoto, T., Inoue, S., Obama, K., Kawahara, K., & Nakayama, H. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.11.011 · Cited by 44
Tang, Y., He, Y., Li, C., Mu, W., Zou, Y., Liu, C., Qian, S., Zhang, F., Pan, J., Wang, Y., et al. (2018) · Cell Discovery · doi:10.1038/s41421-018-0041-2 · Cited by 46
Choi, Y. J., Lee, D. H., Han, K.-D., Yoon, H., Shin, C. M., Park, Y. S., & Kim, N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201308 · Cited by 44
Al-Lahham, S., & Rezaee, F. (2019) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-019-00294-z · Cited by 44
A MAFG-lncRNA axis links systemic nutrient abundance to hepatic glucose metabolism
Pradas-Juni, M., Hansmeier, N. R., Link, J. C., Schmidt, E. B., Larsen, B. D., Klemm, P., Meola, N., Topel, H., Loureiro, R., Dhaouadi, I., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-14323-y · Cited by 44
Jahandideh, F., & Wu, J. (2022) · Food Science and Human Wellness · doi:10.1016/j.fshw.2022.06.001 · Cited by 48
Bonacasa, B., Siow, R. C. M., & Mann, G. E. (2011) · Microcirculation · doi:10.1111/j.1549-8719.2011.00088.x · Cited by 43
Hanzu, F. A., Palomo, M., Kalko, S. G., Párrizas, M., Garaulet, M., Escolar, G., Gomis, R., & Díaz‐Ricart, M. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04285.x · Cited by 43
Tolpin, D. A., Collard, C. D., Lee, V., Elayda, M. A., & Pan, W. (2009) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2009.02.019 · Cited by 43
Lipotoxicity and cardiac dysfunction in mammals andDrosophila
Birse, R. T., & Bodmer, R. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.599830 · Cited by 43
Małyszko, J., Małyszko, J., Pawlak, K., & Myśliwiec, M. (2008) · Advances in Medical Sciences · doi:10.2478/v10039-008-0024-x · Cited by 43
Impact of Nutrition on Cerebral Circulation and Cognition in the Metabolic Syndrome
Mellendijk, L., Wiesmann, M., & Kiliaan, A. J. (2015) · Nutrients · doi:10.3390/nu7115477 · Cited by 44
“The adipokines TNF-α and interleukin 6 (IL-6) may furthermore indirectly influence inflammation processes and endothelial dysfunction [48].”
BackgroundVisceral fat and coronary artery calcification in patients with chronic kidney disease
Cordeiro, A. C., Qureshi, A. R., Lindholm, B., Amparo, F. C., Tito-Paladino-Filho, A., Perini, M., Lourenco, F. S., Pinto, I. M. F., Amodeo, C., & Carrero, J. J. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gft250 · Cited by 43
“However, excess abdominal adiposity may be, at the same time, a direct cardiovascular risk factor by virtue of the endocrine activity of both adipocytes and adipose tissue macrophages [38].”
BackgroundKim, B., Lee, S. G., Park, Y., Ku, C. S., Pham, T. X., Wegner, C., Yang, Y. J., Koo, S. I., Chun, O. K., & Lee, J. (2016) · Nutrition Research and Practice · doi:10.4162/nrp.2016.10.5.494 · Cited by 43
“Hyperlipidemia, a contributor to oxidative stress and inflammation, is a major risk factor for CVD and is positively associated with obesity [5].”
BackgroundKefir prevented excess fat accumulation in diet-induced obese mice
Choi, J.-W., Kang, H. W., Lim, W.-C., Kim, M.-K., Lee, I.-Y., & Cho, H.-Y. (2017) · Bioscience, Biotechnology, and Biochemistry · doi:10.1080/09168451.2016.1258984 · Cited by 43
Wu, Q., Ma, Y., Liu, Y., Wang, N., Zhao, X., & Wen, D. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118424 · Cited by 44
Zhu, Y., Li, A. M., Au, C. T., Kong, A. P. S., Zhang, J., Wong, C. K., Chan, J. C. N., & Wing, Y. K. (2015) · Journal of Diabetes · doi:10.1111/1753-0407.12138 · Cited by 42
Molecular Mechanisms of Exercise and Healthspan
Guan, Y., & Yan, Z. (2022) · Cells · doi:10.3390/cells11050872 · Cited by 48
Sha, B., Gao, W., Wang, S., Gou, X., Li, W., Liang, X., Qu, Z., Xu, F., & Lu, T. J. (2013) · Journal of Applied Toxicology · doi:10.1002/jat.2900 · Cited by 44
“…playing important roles in disease progression of fatty liver disease, type 2 diabetes, Parkinson’s disease and heart failure (CodonerFranch et al., 2010; Desai et al., 2010; Dut et al., 2008; Hoek and Pastorino, 2002; Jenner, 2003; Mantena et al., 2008; Nojiri et al., 2006; Van Gaal et al., 2006).”
BackgroundLin, J. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00053 · Cited by 46
Bidulescu, A., Liu, J., Chen, Z., Hickson, D. A., Musani, S. K., Samdarshi, T. E., Fox, E. R., Taylor, H. A., & Gibbons, G. H. (2013) · Frontiers in Public Health · doi:10.3389/fpubh.2013.00016 · Cited by 42
“INTRODUCTION Significant research has been conducted in order to understand the obesity mechanisms related to cardiovascular disease (CVD) pathogenesis (1).”
BackgroundWolf, D., Jehle, F., Rodríguez, A. O., Dufner, B., Hoppe, N., Colberg, C., Lozhkin, A. P., Bassler, N., Rupprecht, B., Wiedemann, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033026 · Cited by 42
“Beyond this local effect, inflamed adipose tissue propagates a systemic inflammation predisposing for insulin resistance and cardiovascular pathologies such as atherosclerosis [17,18].”
BackgroundSanches, Í. C., Brito, J. D. O., Cândido, G. O., Dias, D. D. S., Jorge, L., Irigoyen, M. C., & Angelis, K. D. (2011) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0b013e3182358c9c · Cited by 42
“Adipose tissue is an active endocrine and paracrine organ that releases a large number of cytokines and bioactive mediators, such as leptin, adiponectin, interleukin-6, and tumor necrosis factorY>, which negatively influences glucose and lipid homeostasis, blood pressure, coagulation, fibrinolysis, and inflammation, p…”
BackgroundOka, R., Yagi, K., Sakurai, M., Nakamura, K., Nagasawa, S., Miyamoto, S., Nohara, A., Kawashiri, M., Hayashi, K., Takeda, Y., et al. (2012) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.12294 · Cited by 42
An Evolutionary Perspective of Nutrition and Inflammation as Mechanisms of Cardiovascular Disease
Rubio-Ruiz, M. E., Peredo-Escárcega, A. E., Cano-Martı́nez, A., & Guarner‐Lans, V. (2015) · International Journal of Evolutionary Biology · doi:10.1155/2015/179791 · Cited by 43
“The use of inflammatory biomarkers for detecting the risk of atherosclerosis and other cardiovascular and metabolic disorders has increased and their detection is becoming more widespread complementing the use of plasma lipid profiles [65, 66].”
BackgroundJasinski‐Bergner, S., Büttner, M., Quandt, D., Seliger, B., & Kielstein, H. (2017) · Obesity Facts · doi:10.1159/000481732 · Cited by 42
Ricci, C., Baumgartner, J., Zec, M. M., Kruger, H. S., & Smuts, C. M. (2018) · British Journal Of Nutrition · doi:10.1017/s0007114517003889 · Cited by 47
Mozaffari, H., Daneshzad, E., Larijani, B. A., Surkan, P. J., & Azadbakht, L. (2019) · Nutrition · doi:10.1016/j.nut.2019.110577 · Cited by 41
Endothelial Dysfunction in Dyslipidaemia: Molecular Mechanisms and Clinical Implications
Zarić, B. L., Obradovic, M. M., Trpković, A., Banach, M., Mikhailidis, D. P., & Isenović, E. R. (2019) · Current Medicinal Chemistry · doi:10.2174/0929867326666190903112146 · Cited by 44
Edible Mushrooms: Novel Medicinal Agents to Combat Metabolic Syndrome and Associated Diseases
Tung, Y., Pan, C., Chien, Y., & Huang, H.-Y. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200831151316 · Cited by 42
Rahimi, G. R. M., Yousefabadi, H. A., Niyazi, A., Rahimi, N. M., & Alikhajeh, Y. (2021) · Biological Research For Nursing · doi:10.1177/10998004211044754 · Cited by 43
“Excessive fat accumulation might be connected to obesity-related MS and macrovascular complications via activation of the immune system and chronic low-grade inflammation (Esser et al., 2014; Van Gaal et al., 2006).”
BackgroundWee, C. C., Girotra, S. R., Weinstein, A. R., Mittleman, M. A., & Mukamal, K. J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.05.021 · Cited by 42
Adipose tissue gene expression and metabolic health of obese adults
Das, S. K., Ma, L., & Sharma, N. K. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.210 · Cited by 42
“This process may be mechanistically linked to the development of obesity-associated metabolic disorders (6;7).”
Metadata
- Authors
- Van Gaal, L. F., Mertens, I. L., & De Block, C. E.
- Affiliations
- University of Antwerp (BE)
- Venue
- Nature
- Published
- 2006-12
- Volume
- 444
- Issue
- 7121
- Pages
- 875-880
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1964607854
- Cited by
- 2,814
- References
- 86
- Citations by year
- 2026: 64 · 2025: 97 · 2024: 126 · 2023: 137 · 2022: 151 · 2021: 172 · 2020: 179 · 2019: 204 · 2018: 172 · 2017: 173 · 2016: 168 · 2015: 193 · 2014: 194 · 2013: 152 · 2012: 128
- FWCI
- 11.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- obesity, cardiovascular disease, adipose tissue, adipokines, insulin resistance, type 2 diabetes, dyslipidemia, blood pressure, coagulation, fibrinolysis, inflammation, endothelial dysfunction, atherosclerosis, smoking, physical activity, premature mortality
- MeSH terms
- Cardiovascular Diseases, Endothelium, Vascular, Humans, Insulin Resistance, Obesity, Oxidative Stress, Adiposity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review